BTC
MRNA icon

Bank & Trust Company’s Moderna MRNA Stock Holding History

Bank & Trust Company’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.4K Hold
306
– – 0.01% 207
2026
Q1 		$15.5K Hold
306
– – 0.01% 217
2025
Q4 		$9.02K Hold
306
– – 0.01% 238
2025
Q3 		$7.9K Hold
306
– – 0.01% 232
2025
Q2 		$8.44K Hold
306
– – 0.01% 233
2025
Q1 		$8.68K Hold
306
– – 0.01% 232
2024
Q4 		$12.7K Hold
306
– – 0.01% 214
2024
Q3 		$20.4K Hold
306
– – 0.02% 187
2024
Q2 		$36.3K Buy
+306
New +$38.7K 0.03% 157

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Bank & Trust Company's MRNA Position: Q2 2026 in Review

Bank & Trust Company held its Moderna (MRNA) position steady in Q2 2026 at 306 shares worth $21.4K. The position accounts for 0.01% of the portfolio, ranked #207.

Bank & Trust Company first reported a position in MRNA in Q2 2024 and has held it in 9 quarters since. The position peaked at $36.3K in Q2 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Bank & Trust Company held 306 shares of Moderna worth $21.4K as of Q2 2026.
  • Bank & Trust Company left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.01% of Bank & Trust Company's portfolio in Q2 2026, its #207 holding.
  • Bank & Trust Company first reported a position in Moderna in Q2 2024 and has held it in 9 quarters since.
  • Bank & Trust Company's Moderna position peaked at $36.3K in Q2 2024.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Bank & Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.